NEURONAL CEROID-LIPOFUSCINOSES
Clinical trials for NEURONAL CEROID-LIPOFUSCINOSES explained in plain language.
Never miss a new study
Get alerted when new NEURONAL CEROID-LIPOFUSCINOSES trials appear
Sign up with your email to follow new studies for NEURONAL CEROID-LIPOFUSCINOSES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to measure how CLN2 affects Kids' skills over time
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 30 children with CLN2 Batten disease to measure changes in thinking, movement, and language skills over time. Researchers will compare children who receive the treatment cerliponase alfa with those who do not. The goal is to find better ways to track the diseas…
Matched conditions: NEURONAL CEROID-LIPOFUSCINOSES
Sponsor: Jessica Scherr • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
Rare disease study tracks symptoms in atypical TPP1 deficiency patients
Knowledge-focused OngoingThis study follows about 5 people with a rare, late-onset form of TPP1 deficiency (also called CLN2 disease) to track their symptoms over time. Researchers will use tests like brain scans, eye exams, and movement assessments to learn how the disease progresses. The goal is to gat…
Matched conditions: NEURONAL CEROID-LIPOFUSCINOSES
Sponsor: Children's Hospital of Orange County • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC